Bank of New York Mellon’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q1 | – | Sell |
-5,100
| Closed | -$268K | – | 4307 |
|
2016
Q4 | $268K | Buy |
5,100
+100
| +2% | +$5.26K | ﹤0.01% | 3813 |
|
2016
Q3 | $287K | Hold |
5,000
| – | – | ﹤0.01% | 3776 |
|
2016
Q2 | $293K | Sell |
5,000
-6
| -0.1% | -$352 | ﹤0.01% | 3754 |
|
2016
Q1 | $287K | Buy |
5,006
+5
| +0.1% | +$287 | ﹤0.01% | 3659 |
|
2015
Q4 | $327K | Sell |
5,001
-65
| -1% | -$4.25K | ﹤0.01% | 3671 |
|
2015
Q3 | $319K | Sell |
5,066
-1,734
| -26% | -$109K | ﹤0.01% | 3709 |
|
2015
Q2 | $481K | Sell |
6,800
-1
| -0% | -$71 | ﹤0.01% | 3651 |
|
2015
Q1 | $478K | Buy |
6,801
+1
| +0% | +$70 | ﹤0.01% | 3626 |
|
2014
Q4 | $437K | Hold |
6,800
| – | – | ﹤0.01% | 3668 |
|
2014
Q3 | $432K | Hold |
6,800
| – | – | ﹤0.01% | 3682 |
|
2014
Q2 | $422K | Sell |
6,800
-1
| -0% | -$62 | ﹤0.01% | 3654 |
|
2014
Q1 | $397K | Buy |
6,801
+1,801
| +36% | +$105K | ﹤0.01% | 3645 |
|
2013
Q4 | $266K | Hold |
5,000
| – | – | ﹤0.01% | 3750 |
|
2013
Q3 | $239K | Hold |
5,000
| – | – | ﹤0.01% | 3719 |
|
2013
Q2 | $227K | Buy |
+5,000
| New | +$227K | ﹤0.01% | 3730 |
|